“Solid tumors are very diverse,” Zhu said. “Some tumor cells lose or hide the antigen a therapy is designed to find — what we ...

De mede-auteur van de studie vertelde aan Newsweek dat deze aanpak zou kunnen helpen bij het aanpakken van uitdagingen die ...

UCLA's AlloESO-T cell therapy targets solid tumors at an estimated $5,000 per dose — a fraction of current costs — but remains in preclinical mouse trials only.

UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through ...

Immunotherapy has revolutionized cancer care by training the immune system to detect and destroy tumors. For many patients, it works very well in shrinking tumors and sending cancer into remission, an ...

Cancer scientists have been working against the clock for decades to outsmart a disease that comes back more powerfully after treatment. Traditional treatments like chemotherapy, radiation, and even ...

T-cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down ...

In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...

Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells – hard-to-find cells that help cancers spread, come back after treatment and resist ...

A woman undergoing cancer treatment will attend a Parkrun to encourage more stem cell donors.